Furthermore, CRNDE modulates autophagy via the PI3K/Akt/mTOR pathway and regulates ABCG2 expression, supporting its candidacy as a novel target for overcoming TMZ resistance in GBM [68]. The gene discussed is ABCG2; the disease is glioblastoma.